Karenann Terrell was appointed Chief Digital & Technology Officer of GlaxoSmithKline on 25th July 2017. She will be responsible for developing GSK’s digital, data, and analytics strategy and the major focus of her work would be to bring new technologies to GSK, enhancing areas such as clinical trials and drug development.
For nearly six and a half years through March of this year, Terrell was Chief Information Officer of Walmart, where she led a multi-year effort to transform Walmart in the use of data, analytics, and digital engagement with its customers.
GSK CEO Emma Walmsley, said: “The impact of technology on the healthcare industry is accelerating and requires us to rethink our approach. As a member of the Executive Team, Karenann will have the scope to think radically about how we can exploit the latest opportunities and ultimately improve our business performance.”
